Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Dianthus Therapeutics Inc (DNTH)

Dianthus Therapeutics Inc (DNTH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Dianthus Therapeutics Inc 7 Times Square 43rd Floor New York NY 10036 USA

www.dianthustx.com Employees: 78 P: 929-999-4055

Sector:

Medical

Description:

Dianthus Therapeutics Inc. is a privately-held, clinical-stage biotechnology company dedicated to advancing the next generation of antibody complement therapeutics. Dianthus Therapeutics Inc., formerly known as Magenta Therapeutics Inc., is based in CAMBRIDGE, Mass.

Key Statistics

Overview:

Market Capitalization, $K 1,890,831
Enterprise Value, $K 1,868,041
Shares Outstanding, K 42,876
Float, K 39,382
% Float 91.85%
Short Interest, K 4,164
Short Float 9.71%
Days to Cover 7.84
Short Volume Ratio 0.64
% of Insider Shareholders 8.15%
% of Institutional Shareholders 47.53%

Financials:

Annual Sales, $ 6,240 K
Annual Net Income, $ -84,970 K
Last Quarter Sales, $ 400 K
Last Quarter Net Income, $ -36,770 K
EBIT, $ -140,320 K
EBITDA, $ -145,930 K

Growth:

1-Year Return 129.57%
3-Year Return 440.44%
5-Year Return -66.43%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 92.30%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.97 on 11/05/25
Next Earnings Date 03/10/26
Earnings Per Share ttm -3.48
EPS Growth vs. Prev Qtr -10.23%
EPS Growth vs. Prev Year -31.08%
Annual Dividend & Yield (Paid) 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-16 on 09/12/23

DNTH Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -33.02%
Return-on-Assets % -31.08%
Profit Margin % -1,361.70%
Debt/Equity 0.00
Price/Sales 518.80
Price/Cash Flow N/A
Price/Book 3.45
Book Value/Share 12.75
Interest Coverage -2.40
60-Month Beta 1.55
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar